Global Immuno-oncology Drugs Market Research Report 2022, Forecast to 2027

Table of Contents

Global Immuno-oncology Drugs Market Research Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Immuno-oncology Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Immuno-oncology Drugs Segment by Type
2.1.1 Immune Checkpoint Inhibitors
2.1.2 Monoclonal Antibodies
2.1.3 Cytokine-Based Immunotherapy
2.1.4 Cancer Vaccines
2.1.5 CAR-T Cell Therapy
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Pharmacies
2.2.3 Online Pharmacies
2.3 Global Immuno-oncology Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Immuno-oncology Drugs Market Size (2017-2027)
2.3.2 North America Immuno-oncology Drugs Status and Prospect (2017-2027)
2.3.3 Europe Immuno-oncology Drugs Status and Prospect (2017-2027)
2.3.4 China Immuno-oncology Drugs Status and Prospect (2017-2027)
2.3.5 Japan Immuno-oncology Drugs Status and Prospect (2017-2027)
2.3.6 Southeast Asia Immuno-oncology Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Immuno-oncology Drugs Industry Impact
2.5.1 Immuno-oncology Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Immuno-oncology Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Immuno-oncology Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Immuno-oncology Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Immuno-oncology Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Immuno-oncology Drugs Manufacturer Market Share
3.5 Top 10 Immuno-oncology Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
3.7 Key Manufacturers Immuno-oncology Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning

4 Analysis of Immuno-oncology Drugs Industry Key Manufacturers
4.1 Amgen, Inc
4.1.1 Compan Detail
4.1.2 Amgen, Inc Immuno-oncology Drugs Product Introduction, Application and Specification
4.1.3 Amgen, Inc 181 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Amgen, Inc News
4.2 AstraZeneca, Plc
4.2.1 Compan Detail
4.2.2 AstraZeneca, Plc Immuno-oncology Drugs Product Introduction, Application and Specification
4.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Amgen, Inc News
4.3 Bristol-Myers Squibb
4.3.1 Compan Detail
4.3.2 Bristol-Myers Squibb Immuno-oncology Drugs Product Introduction, Application and Specification
4.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Bristol-Myers Squibb News
4.4 Celgene Corporation
4.4.1 Compan Detail
4.4.2 Celgene Corporation Immuno-oncology Drugs Product Introduction, Application and Specification
4.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Celgene Corporation News
4.5 Eli Lilly and Company
4.5.1 Compan Detail
4.5.2 Celgene Corporation Immuno-oncology Drugs Product Introduction, Application and Specification
4.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Eli Lilly and Company News
4.6 Merck & Co.
4.6.1 Compan Detail
4.6.2 Merck & Co. Immuno-oncology Drugs Product Introduction, Application and Specification
4.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Merck & Co. News
4.7 Hoffmann-La Roche AG
4.7.1 Compan Detail
4.7.2 Hoffmann-La Roche AG Immuno-oncology Drugs Product Introduction, Application and Specification
4.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Johnson & Johnson
4.8.1 Compan Detail
4.8.2 Johnson & Johnson Immuno-oncology Drugs Product Introduction, Application and Specification
4.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Johnson & Johnson News
4.9 Novartis International AG
4.9.1 Compan Detail
4.9.2 Novartis International AG Immuno-oncology Drugs Product Introduction, Application and Specification
4.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Novartis International AG News
4.10 AbbVie, Inc.
4.10.1 Compan Detail
4.10.2 AbbVie, Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 AbbVie, Inc. News
4.11 Pfizer Inc.
4.11.1 Compan Detail
4.11.2 Pfizer Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Pfizer Inc. News
4.12 Sanofi S.A.
4.12.1 Compan Detail
4.12.2 Sanofi S.A. Immuno-oncology Drugs Product Introduction, Application and Specification
4.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Sanofi S.A. News
4.13 EMD Serono, Inc.
4.13.1 Company Details
4.13.2 EMD Serono, Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 EMD Serono, Inc. News
4.14 Gilead Sciences Inc.
4.14.1 Compan Detail
4.14.2 Gilead Sciences Inc. Immuno-oncology Drugs Product Introduction, Application and Specification
4.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Gilead Sciences Inc. News
4.15 Prometheus Therapeutics & Diagnostics
4.15.1 Compan Detail
4.15.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Introduction, Application and Specification
4.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Prometheus Therapeutics & Diagnostics News
4.16 Aduro BioTech
4.16.1 Compan Detail
4.16.2 Aduro BioTech Immuno-oncology Drugs Product Introduction, Application and Specification
4.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Aduro BioTech News
4.17 Galena Biopharma
4.17.1 Compan Detail
4.17.2 Galena Biopharma Immuno-oncology Drugs Product Introduction, Application and Specification
4.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Galena Biopharma News
4.18 Bavarian Nordic
4.18.1 Compan Detail
4.18.2 Bavarian Nordic Immuno-oncology Drugs Product Introduction, Application and Specification
4.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Bavarian Nordic News
4.19 Celldex Therapeutics
4.19.1 Compan Detail
4.19.2 Celldex Therapeutics Immuno-oncology Drugs Product Introduction, Application and Specification
4.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Celldex Therapeutics News
4.20 ImmunoCellular Therapeutics
4.20.1 Compan Detail
4.20.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Introduction, Application and Specification
4.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 ImmunoCellular Therapeutics News
4.21 Incyte
4.21.1 Compan Detail
4.21.2 Incyte Immuno-oncology Drugs Product Introduction, Application and Specification
4.21.3 Incyte Immuno-oncology Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.21.4 Main Business Overview
4.21.5 Incyte News

5 Global Immuno-oncology Drugs Market Segment by Big Type
5.1 Global Immuno-oncology Drugs Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Immuno-oncology Drugs Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Immuno-oncology Drugs Revenue and Market Share by Big Type (2017-2022)
5.2 Immune Checkpoint Inhibitors Sales Growth Rate and Price
5.2.1 Global Immune Checkpoint Inhibitors Sales Growth Rate (2017-2022)
5.2.2 Global Immune Checkpoint Inhibitors Price (2017-2022)
5.3 Monoclonal Antibodies Sales Growth Rate and Price
5.3.1 Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
5.3.2 Global Monoclonal Antibodies Price (2017-2022)
5.4 Cytokine-Based Immunotherapy Sales Growth Rate and Price
5.4.1 Global Cytokine-Based Immunotherapy Sales Growth Rate (2017-2022)
5.4.2 Global Cytokine-Based Immunotherapy Price (2017-2022)
5.5 Cancer Vaccines Sales Growth Rate and Price
5.5.1 Global Cancer Vaccines Sales Growth Rate (2017-2022)
5.5.2 Global Cancer Vaccines Price (2017-2022)
5.6 CAR-T Cell Therapy Sales Growth Rate and Price
5.6.1 Global CAR-T Cell Therapy Sales Growth Rate (2017-2022)
5.6.2 Global CAR-T Cell Therapy Price (2017-2022)

6 Global Immuno-oncology Drugs Market Segment by Big Application
6.1 Global Immuno-oncology Drugs Sales Market Share by Big Application (2017-2022)
6.2 Hospitals Sales Growth Rate (2017-2022)
6.3 Pharmacies Sales Growth Rate (2017-2022)
6.4 Online Pharmacies Sales Growth Rate (2017-2022)

7 Global Immuno-oncology Drugs Forecast
7.1 Global Immuno-oncology Drugs Revenue, Sales and Growth Rate (2022-2027)
7.2 Immuno-oncology Drugs Market Forecast by Regions (2022-2027)
7.2.1 North America Immuno-oncology Drugs Market Forecast (2022-2027)
7.2.2 Europe Immuno-oncology Drugs Market Forecast (2022-2027)
7.2.3 China Immuno-oncology Drugs Market Forecast (2022-2027)
7.2.4 Japan Immuno-oncology Drugs Market Forecast (2022-2027)
7.2.5 Southeast Asia Immuno-oncology Drugs Market Forecast (2022-2027)
7.2.6 Other Regions Immuno-oncology Drugs Market Forecast (2022-2027)
7.3 Immuno-oncology Drugs Market Forecast by Type (2022-2027)
7.3.1 Global Immuno-oncology Drugs Sales Forecast by Type (2022-2027)
7.3.2 Global Immuno-oncology Drugs Market Share Forecast by Type (2022-2027)
7.4 Immuno-oncology Drugs Market Forecast by Application (2022-2027)
7.4.1 Global Immuno-oncology Drugs Sales Forecast by Application (2022-2027)
7.4.2 Global Immuno-oncology Drugs Market Share Forecast by Application (2022-2027)

8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis

9 Immuno-oncology Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Immuno-oncology Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers

10 Research Findings and Conclusion


List of Tables and Figures

Figure Product Picture Immuno-oncology Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Immuno-oncology Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Immuno-oncology Drugs Market Size by Big Type
Figure Global Market Share of Immuno-oncology Drugs by Big Type in 2021
Figure Immune Checkpoint Inhibitors Picture (2017-2022)
Figure Monoclonal Antibodies Picture (2017-2022)
Figure Cytokine-Based Immunotherapy Picture (2017-2022)
Figure Cancer Vaccines Picture (2017-2022)
Global Immuno-oncology Drugs Market Size by Big Application
Table Global Immuno-oncology Drugs Market Size by Application
Figure Global Immuno-oncology Drugs Market Share by Big Application in 2021
Figure Hospitals Picture
Figure Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Immuno-oncology Drugs Comparison by Regions (M USD) (2017-2027)
Figure Global Immuno-oncology Drugs Market Size (Million US$) (2017-2027)
Figure North America Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure China Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Immuno-oncology Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Immuno-oncology Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Immuno-oncology Drugs Sales by Manufacturer (2017-2022)
Figure Global Immuno-oncology Drugs Sales Market Share by Manufacturer in 2021
Table Global Immuno-oncology Drugs Revenue by Manufacturer (2017-2022)
Figure Global Immuno-oncology Drugs Revenue Market Share by Manufacturer in 2021
Table Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Immuno-oncology Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Immuno-oncology Drugs Market
Table Key Manufacturers Immuno-oncology Drugs Product Type
Table Mergers & Acquisitions Planning
Table Amgen, Inc Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Amgen, Inc
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table AstraZeneca, Plc Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of AstraZeneca, Plc
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca, Plc Recent Development
Table Bristol-Myers Squibb Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Bristol-Myers Squibb
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Celgene Corporation Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Celgene Corporation
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table Eli Lilly and Company Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Eli Lilly and Company
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly and Company Main Business
Table Eli Lilly and Company Recent Development
Table Merck & Co. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Merck & Co.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co. Main Business
Table Merck & Co. Recent Development
Table Hoffmann-La Roche AG Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Hoffmann-La Roche AG
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hoffmann-La Roche AG Main Business
Table Hoffmann-La Roche AG Recent Development
Table Johnson & Johnson Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Johnson & Johnson
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Novartis International AG Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Novartis International AG
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis International AG Main Business
Table Novartis International AG Recent Development
Table AbbVie, Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of AbbVie, Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AbbVie, Inc. Main Business
Table AbbVie, Inc. Recent Development
Table Pfizer Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Pfizer Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Inc. Main Business
Table Pfizer Inc. Recent Development
Table Sanofi S.A. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Sanofi S.A.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi S.A. Main Business
Table Sanofi S.A. Recent Development
Table EMD Serono, Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of EMD Serono, Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table EMD Serono, Inc. Main Business
Table EMD Serono, Inc. Recent Development
Table Gilead Sciences Inc. Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Gilead Sciences Inc.
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Gilead Sciences Inc. Main Business
Table Gilead Sciences Inc. Recent Development
Table Aduro BioTech Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Aduro BioTech
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aduro BioTech Main Business
Table Aduro BioTech Recent Development
Table Galena Biopharma Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Galena Biopharma
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Galena Biopharma Main Business
Table Galena Biopharma Recent Development
Table Bavarian Nordic Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Bavarian Nordic
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bavarian Nordic Main Business
Table Bavarian Nordic Recent Development
Table Celldex Therapeutics Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Celldex Therapeutics
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Celldex Therapeutics Main Business
Table Celldex Therapeutics Recent Development
Table ImmunoCellular Therapeutics Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of ImmunoCellular Therapeutics
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table ImmunoCellular Therapeutics Main Business
Table ImmunoCellular Therapeutics Recent Development
Table Incyte Company Profile
Table Immuno-oncology Drugs Product Introduction, Application and Specification of Incyte
Table Immuno-oncology Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Incyte Main Business
Table Incyte Recent Development
Figure Global Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Global Immuno-oncology Drugs Revenue and Growth Rate (2017-2022)
Table Global Immuno-oncology Drugs Sales by Regions (2017-2022)
Figure Global Immuno-oncology Drugs Sales Market Share by Regions in 2021
Table Global Immuno-oncology Drugs Revenue by Regions (2017-2022)
Figure Global Immuno-oncology Drugs Revenue Market Share by Regions in 2021
Figure North America Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Europe Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure China Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Japan Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Figure Other Regions Immuno-oncology Drugs Sales and Growth Rate (2017-2022)
Table Global Immuno-oncology Drugs Sales by Big Type (2017-2022)
Table Global Immuno-oncology Drugs Sales Market Share by Big Type (2017-2022)
Figure Global Immuno-oncology Drugs Sales Market Share by Big Type in 2019
Table Global Immuno-oncology Drugs Revenue by Big Type (2017-2022)
Table Global Immuno-oncology Drugs Revenue Market Share by Big Type (2017-2022)
Table Global Immuno-oncology Drugs Revenue Market Share by Big Type in 2019
Figure Global Immune Checkpoint Inhibitors Sales Growth Rate (2017-2022)
Figure Global Immune Checkpoint Inhibitors Price (2017-2022)
Figure Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
Figure Global Monoclonal Antibodies Price (2017-2022)
Figure Global Cytokine-Based Immunotherapy Sales Growth Rate (2017-2022)
Figure Global Cytokine-Based Immunotherapy Price (2017-2022)
Figure Global Cancer Vaccines Sales Growth Rate (2017-2022)
Figure Global Cancer Vaccines Price (2017-2022)
Table Global Immuno-oncology Drugs Sales by Big Application (2017-2022)
Table Global Immuno-oncology Drugs Sales Market Share by Big Application (2017-2022)
Figure Global Immuno-oncology Drugs Sales Market Share by Big Application in 2019
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Pharmacies Sales Growth Rate (2017-2022)
Figure Global Online Pharmacies Sales Growth Rate (2017-2022)
Figure Global Immuno-oncology Drugs Sales and Growth Rate (2022-2027)
Figure Global Immuno-oncology Drugs Revenue and Growth Rate (2022-2027)
Table Global Immuno-oncology Drugs Sales Forecast by Regions (2022-2027)
Table Global Immuno-oncology Drugs Market Share Forecast by Regions (2022-2027)
Figure North America Sales Immuno-oncology Drugs Market Forecast (2022-2027)
Figure Europe Sales Immuno-oncology Drugs Market Forecast (2022-2027)
Figure China Sales Immuno-oncology Drugs Market Forecast (2022-2027)
Figure Japan Sales Immuno-oncology Drugs Market Forecast (2022-2027)
Figure Southeast Asia Sales Immuno-oncology Drugs Market Forecast (2022-2027)
Figure Other Regions Sales Immuno-oncology Drugs Market Forecast (2022-2027)
Table Global Immuno-oncology Drugs Sales Forecast by Type (2022-2027)
Table Global Immuno-oncology Drugs Market Share Forecast by Type (2022-2027)
Table Global Immuno-oncology Drugs Sales Forecast by Application (2022-2027)
Table Global Immuno-oncology Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immuno-oncology Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Immuno-oncology Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Immuno-oncology Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Immuno-oncology Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Immuno-oncology Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Immuno-oncology Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Immuno-oncology Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Immuno-oncology Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Immuno-oncology Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List

Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics